GENTA INCORPORATED /DE/
8-K, 1999-02-12
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: MAGAININ PHARMACEUTICALS INC, 5, 1999-02-12
Next: UNITED STATES CAN COMPANY /DE/, SC 13G/A, 1999-02-12




                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT


     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



Date of Report (Date of earliest event reported):  February 10, 1999


                               GENTA INCORPORATED
             (Exact name of registrant as specified in its charter)

                         Commission file number 0-19635

           Delaware                                      33-0326866
(State or other jurisdiction of             (IRS Employer Identification Number)
incorporation or organization)


                 3550 General Atomics Court, San Diego, CA 92121
                    (Address of principal executive offices)
                                   (Zip Code)


                                 (619) 455-2700
              (Registrant's telephone number, including area code)


<PAGE>



                               GENTA INCORPORATED

                                    FORM 8-K

                                 CURRENT REPORT

                                TABLE OF CONTENTS


Item 4.        Changes in Registrant's Certifying Accountant


Signature



                                      - 2 -

<PAGE>

ITEM 4.        Changes in Registrant's Certifying Accountant

        On November 3, 1998, Genta Incorporated (the "Registrant")  filed a Form
8-K announcing that Ernst & Young LLP had resigned as the Registrant's principal
independent accountant on October 28, 1998.

        On February 10, 1999,  Genta  Incorporated  (the  "Registrant")  engaged
Deloitte  &  Touche  LLP  ("D&T")  as the  principal  accountant  to  audit  the
Registrant's financial statements.

         During the  Registrant's  fiscal  years  ending  December  31, 1996 and
December 31, 1997 and the subsequent  interim period preceding the engagement of
D&T, neither the Registrant nor anyone on its behalf consulted D&T regarding the
application  of  accounting  principles  to a  specific  completed  or  proposed
transaction,  or the  type of  audit  opinion  that  might  be  rendered  on the
Registrant's financial statements,  which consultation resulted in the providing
of a written report or oral advice  concerning  the same to the Registrant  that
D&T concluded was an important factor considered by the Registrant in reaching a
decision as to the accounting, auditing or financial reporting issue.


                                      - 3 -

<PAGE>

                                    SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Date: February 11, 1999


                                        GENTA INCORPORATED



                                        /s/ Kenneth G. Kasses, Ph.D.
                                        ----------------------------
                                        Kenneth G. Kasses, Ph.D.
                                        President, Principal Executive Officer
                                        and Chairman of the Board


                                      - 4 -



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission